Taxanes: Microtubule and centrosome targets, and cell cycle dependent mechanisms of action

Current Cancer Drug Targets

Volumn 3, Issue 3, 2003, Pages 193-203

  Abal, M ^a   Andreu, J M ^b   Barasoain, I ^b  

^a CNRS   (France)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; ANTINEOPLASTIC AGENT; BACCATIN III; BETA TUBULIN; COLCHICINE; CRYPTOPHYCIN DERIVATIVE; CYTOTOXIC AGENT; DISCODERMOLIDE; DOCETAXEL; ELEUTHEROBIN; EPOTHILONE DERIVATIVE; FLUORESCENT DYE; LAULIMALIDE; PACLITAXEL; PROTEIN BCL 2; PROTEIN P53; TAXANE DERIVATIVE; VINCA ALKALOID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CANCER CHEMOTHERAPY; CELL CYCLE; CELL CYCLE G1 PHASE; CENTROSOME; DRUG MECHANISM; DRUG SENSITIVITY; HUMAN; MICROTUBULE; MICROTUBULE ASSEMBLY; MITOSIS SPINDLE; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CENTROSOME; DRUG DELIVERY SYSTEMS; HUMANS; MICROTUBULES; PACLITAXEL;

EID: 0038216623     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009033481967     Document Type: Review

References (152)

1. Nogales, E. Structural Insight into Microtubule Function. Annu. Rev. Biophys. Biomol. Struct. 2001, 30, 397-420.
2. Carlier, M. F. Role of Nucleotide Hydrolysis in the Dynamics of Actin Filaments and Microtubules. Int. Rev. Cytol. 1989, 115, 139-170.
3. Tilney, L. G.; Bryan, J.; Bush, D. J.; Fujiwara, K.; Mooseker, M. S.; Murphy, D. B.; Snyder, D. H. Microtubules: Evidence for 13 Protofilaments. J. Cell. Biol. 1973, 59, 267-275.
4. Zheng, Y.; Wong, M. L.; Alberts, B.; Mitchison, T. Nucleation of Microtubule Assembly by a Gamma-Tubulin-Containing Ring Complex. Nature 1995, 378, 578-583.
5. Carlier, M. F.; Pantaloni, D. Kinetic Analysis of Cooperativity in Tubulin Polymerization in the Presence of Guanosine Di- or Triphosphate Nucleotides. Biochemistry 1978, 17, 1908-1915.
6. Margolis, R. L.; Wilson, L. Microtubule Treadmilling: What Goes Around Comes Around. Bioessays 1998, 20, 830-836.
7. Waterman-Storer, C. M.; Salmon, E. D. Microtubule Dynamics: Treadmilling Comes around Again. Curr. Biol. 1997, 7, R369-R372.
8. Mitchison, T.; Kirschner, M. Dynamic Instability of Microtubule Growth. Nature 1984, 312, 237-42.
9. Nogales, E. A Structural View of Microtubule Dynamics. Cell Mol. Life Sci. 1999, 56, 133-142.
10. Hyman, A. A.; Karsenti, E. Morphogenetic Properties of Microtubules and Mitotic Spindle Assembly. Cell 1996, 84, 401-410.
11. Holy, T. E.; Leibler, S. Dynamic Instability of Microtubules as an Efficient Way to Search in Space. Proc. Natl. Acad. Sci. USA 1994, 91, 5682-5685.
12. Belmont, L. D.; Mitchison, T. J. Identification of a Protein That Interacts with Tubulin Dimers and Increases the Catastrophe Rate of Microtubules. Cell 1996, 84, 623-631.
13. Cassimeris, L. The Oncoprotein 18/Stathmin Family of Microtubule Destabilizers. Curr. Opin. Cell Biol. 2002, 14, 18-24.
14. Walczak, C. E.; Mitchison, T. J.; Desai, A. Xkcm1: A Xenopus Kinesin-Related Protein That Regulates Microtubule Dynamics During Mitotic Spindle Assembly. Cell 1996, 84, 37-47.
15. Vasquez, R. J.; Gard, D. L.; Cassimeris, L. Xmap from Xenopus Eggs Promotes Rapid Plus End Assembly of Microtubules and Rapid Microtubule Polymer Turnover. J. Cell Biol. 1994, 127, 985-993.
16. Goldstein, L. S.; Philp, A. V. The Road Less Traveled: Emerging Principles of Kinesin Motor Utilization. Annu. Rev. Cell Dev. Bio. 1999, 15, 141-183.
17. King, S. M. The Dynein Microtubule Motor. Biochim. Biophys. Acta 2000, 1496, 60-75.
18. Sharp, D. J.; Brown, H. M.; Kwon, M.; Rogers, G. C.; Holland, G.; Scholey, J. M. Functional Coordination of Three Mitotic Motors in Drosophila Embryos. Mol. Biol. Cell 2000, 11, 241-253.
19. Walczak, C. E.; Vernos, I.; Mitchison, T. J.; Karsenti, E.; Heald, R. A Model for the Proposed Roles of Different Microtubule-Based Motor Proteins in Establishing Spindle Bipolarity. Curr. Biol. 1998, 8, 903-913.
20. Dionne, M. A.; Howard, L.; Compton, D. A. Numa Is a Component of an Insoluble Matrix at Mitotic Spindle Poles. Cell Motil. Cytoskeleton 1999, 42, 189-203.
21. Doxsey, S. The Centrosome - a Tiny Organelle with Big Potential. Nat. Genet. 1998, 20, 104-106.
22. Morgan, S. E.; Kastan, M. B. p53 and ATM: Cell Cycle, Cell Death, and Cancer. Adv. Cancer Res. 1997, 71, 1-25.
23. Rowinsky, E. K. The Development and Clinical Utility of the Taxane Class of Antimicrotubule Chemotherapy Agents. Annu. Rev. Med. 1997, 48, 353-374.
24. Jordan, M. A.; Wilson, L. Microtubules and Actin Filaments: Dynamic Targets for Cancer Chemotherapy. Curr. Opin. Cell Biol. 1998, 10, 123-130.
25. Bollag, D. M.; McQueney, P. A.; Zhu, J.; Hensens, O.; Koupal, L.; Liesch, J.; Goetz, M.; Lazarides, E.; Woods, C. M. Epothilones, a New Class of Microtubule-Stabilizing Agents with a Taxol-Like Mechanism of Action. Cancer Res. 1995, 55, 2325-2333.
26. ter Haar, E.; Kowalski, R. J.; Hamel, E.; Lin, C. M.; Longley, R. E.; Gunasekera, S. P.; Rosenkranz, H. S.; Day, B. W. Discodermolide, a Cytotoxic Marine Agent That Stabilizes Microtubules More Potently Than Taxol. Biochemistry 1996, 35, 243-250.
27. Long, B. H.; Carboni, J. M.; Wasserman, A. J.; Cornell, L. A.; Casazza, A. M.; Jensen, P. R.; Lindel, T.; Fenical, W.; Fairchild, C. R. Eleutherobin, a Novel Cytotoxic Agent That Induces Tubulin Polymerization, Is Similar to Paclitaxel (Taxol). Cancer Res. 1998, 58, 1111-1115.
28. Downing, K. H. Structural Basis for the Interaction of Tubulin with Proteins and Drugs That Affect Microtubule Dynamics. Annu. Rev. Cell Dev. Biol. 2000, 16, 89-111.
29. Mooberry, S. L.; Tien, G.; Hernandez, A. H.; Plubrukarn, A.; Davidson, B. S. Laulimalide and Isolaulimalide, New Paclitaxel-Like Microtubule-Stabilizing Agents. Cancer Res. 1999, 59, 653-660.
30. Pryor, D. E.; O'Brate, A.; Bilcer, G.; Diaz, J. F.; Wang, Y.; Kabaki, M.; Jung, M. K.; Andreu, J. M.; Ghosh, A. K.; Giannakakou, P.; Hamel, E. The Microtubule Stabilizing Agent Laulimalide Does Not Bind in the Taxoid Site, Kills Cells Resistant to Paclitaxel and Epothilones, and May Not Require Its Epoxide Moiety for Activity. Biochemistry 2002, 41, 9109-9115.
31. Kingston, D. G. Recent Advances in the Chemistry of Taxol. J. Nat. Prod. 2000, 63, 726-734.
32. Lataste, H.; Senilh, V.; Wright, M.; Guenard, D.; Potier, P. Relationships between the Structures of Taxol and Baccatine III. Derivatives and Their in Vitro Action on the Disassembly of Mammalian Brain and Physarum Amoebal Microtubules. Proc. Natl. Acad. Sci. USA 1984, 81, 4090-4.
33. Suffness, M. Is Taxol a Surrogate for a Universal Regulator of Mitosis? In Vivo 1994, 8, 867-878.
34. He, L.; Jagtap, P. G.; Kingston, D. G.; Shen, H. J.; Orr, G. A.; Horwitz, S. B. A Common Pharmacophore for Taxol and the Epothilones Based on the Biological Activity of a Taxane Molecule Lacking a C-13 Side Chain. Biochemistry 2000, 39, 3972-3978.
35. Miller, M. C., 3rd; Johnson, K. R.; Willingham, M. C.; Fan, W. Apoptotic Cell Death Induced by Baccatin Iii, a Precursor of Paclitaxel, May Occur without G(2)/M Arrest. Cancer Chemother. Pharmacol. 1999, 44, 444-452.
36. Giannakakou, P.; Gussio, R.; Nogales, E.; Downing, K. H.; Zaharevitz, D.; Bollbuck, B.; Poy, G.; Sackett, D.; Nicolaou, K. C.; Fojo, T. A Common Pharmacophore for Epothilone and Taxanes: Molecular Basis for Drug Resistance Conferred by Tubulin Mutations in Human Cancer Cells. Proc. Natl. Acad. Sci. USA 2000, 97, 2904-2909.
37. Li, Y.; Poliks, B.; Cegelski, L.; Poliks, M.; Gryczynski, Z.; Piszczek, G.; Jagtap, P. G.; Studelska, D. R.; Kingston, D. G.; Schaefer, J.; Bane, S. Conformation of Microtubule-Bound Paclitaxel Determined by Fluorescence Spectroscopy and Redor NMR. Biochemistry 2000, 39, 281-91.
38. Rao, S.; He, L.; Chakravarty, S.; Ojima, I.; Orr, G. A.; Horwitz, S. B. Characterization of the Taxol Binding Site on the Microtubule. Identification of Arg(282) in Beta-Tubulin as the Site of Photoincorporation of a 7-Benzophenone Analogue of Taxol. J. Biol. Chem. 1999, 274, 37990-37994.
39. Snyder, J. P.; Nettles, J. H.; Cornett, B.; Downing, K. H.; Nogales, E. The Binding Conformation of Taxol in Beta-Tubulin: A Model Based on Electron Crystallographic Density. Proc. Natl. Acad. Sci. USA 2001, 98, 5312-5316.
40. Andreu, J. M.; Barasoain, I. The Interaction of Baccatin Iii with the Taxol Binding Site of Microtubules Determined by a Homogeneous Assay with Fluorescent Taxoid. Biochemistry 2001, 40, 11975-11984.
41. Jordan, M. A.; Toso, R. J.; Thrower, D.; Wilson, L. Mechanism of Mitotic Block and Inhibition of Cell Proliferation by Taxol at Low Concentrations. Proc. Natl. Acad. Sci. USA 1993, 90, 9552-9556.
42. Yvon, A. M.; Wadsworth, P.; Jordan, M. A. Taxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells. Mol. Biol. Cell 1999, 10, 947-959.
43. Abal, M.; Souto, A. A.; Amat-Guerri, F.; Acuna, A. U.; Andreu, J. M.; Barasoain, I. Centrosome and Spindle Pole Microtubules Are Main Targets of a Fluorescent Taxoid Inducing Cell Death. Cell Motil. Cytoskeleton 2001, 49, 1-15.
44. Jordan, M. A.; Wendell, K.; Gardiner, S.; Derry, W. B.; Copp, H.; Wilson, L. Mitotic Block Induced in Hela Cells by Low Concentrations of Paclitaxel (Taxol) Results in Abnormal Mitotic Exit and Apoptotic Cell Death. Cancer Res. 1996, 56, 816-825.
45. Lin, H. L.; Chang, Y. F.; Liu, T. Y.; Wu, C. W.; Chi, C. W. Submicromolar Paclitaxel Induces Apoptosis in Human Gastric Cancer Cells at Early G1 Phase. Anticancer Res. 1998, 18, 3443-3449.
46. Woods, C. M.; Zhu, J.; McQueney, P. A.; Bollag, D.; Lazarides, E. Taxol-Induced Mitotic Block Triggers Rapid Onset of a P53-Independent Apoptotic Pathway. Mol. Med. 1995, 1, 506-526.
47. Milas, L.; Hunter, N. R.; Kurdoglu, B.; Mason, K. A.; Meyn, R. E.; Stephens, L. C.; Peters, L. J. Kinetics of Mitotic Arrest and Apoptosis in Murine Mammary and Ovarian Tumors Treated with Taxol. Cancer Chemother. Pharmacol. 1995, 35, 297-303.
48. Milross, C. G.; Mason, K. A.; Hunter, N. R.; Chung, W. K.; Peters, L. J.; Milas, L. Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of Paclitaxel. J Natl. Cancer Inst. 1996, 88, 1308-1314.
49. De Brabander, M.; Geuens, G.; Nuydens, R.; Willebrords, R.; De Mey, J. Taxol Induces the Assembly of Free Microtubules in Living Cells and Blocks the Organizing Capacity of the Centrosomes and Kinetochores. Proc. Natl. Acad. Sci. USA 1981, 78, 5608-5612.
50. Novakova, M.; Draberova, E.; Schurmann, W.; Czihak, G.; Viklicky, V.; Dr-aber, P. Gamma-Tubulin Redistribution in Taxol-Treated Mitotic Cells Probed by Monoclonal Antibodies. Cell Motil. Cytoskeleton 1996, 33, 38-51.
51. Chen, J. G.; Horwitz, S. B. Differential Mitotic Responses to Microtubule-Stabilizing and -Destabilizing Drugs. Cancer Res. 2002, 62, 1935-1938.
52. Torres, K.; Horwitz, S. B. Mechanisms of Taxol-Induced Cell Death Are Concentration Dependent. Cancer Res. 1998, 58, 3620-3626.
53. Souto, A. A.; Acuna, A. U.; Andreu, J. M.; Barasoain, I.; Abal, M.; Amat-Guerri, F. New Fluorescent Water-Soluble Taxol Derivatives. Angew. Chem. Int. Ed. Engl. 1995, 34, 2710-2712.
54. Evangelio, J. A.; Abal, M.; Barasoain, I.; Souto, A. A.; Lillo, M. P.; Acuna, A. U.; Amat-Guerri, F.; Andreu, J. M. Fluorescent Taxoids as Probes of the Microtubule Cytoskeleton. Cell Motil. Cytoskeleton 1998, 39, 73-90.
55. Long, B. H.; Fairchild, C. R. Paclitaxel Inhibits Progression of Mitotic Cells to G1 Phase by Interference with Spindle Formation without Affecting Other Microtubule Functions During Anaphase and Telephase. Cancer Res. 1994, 54, 4355-4361.
56. Fisk, H. A.; Winey, M. The Mouse Mps1p-Like Kinase Regulates Centrosome Duplication. Cell 2001, 106, 95-104.
57. Okuda, M.; Horn, H. F.; Tarapore, P.; Tokuyama, Y.; Smulian, A. G.; Chan, P. K.; Knudsen, E. S.; Hofmann, I. A.; Snyder, J. D.; Bove, K. E.; Fukasawa, K. Nucleophosmin/B23 Is a Target of Cdk2/Cyclin E in Centrosome Duplication. Cell 2000, 103, 127-140.
58. Freed, E.; Lacey, K. R.; Huie, P.; Lyapina, S. A.; Deshaies, R. J.; Stearns, T.; Jackson, P. K. Components of an Scf Ubiquitin Ligase Localize to the Centrosome and Regulate the Centrosome Duplication Cycle. Genes Dev. 1999, 13, 2242-2257.
59. Nakayama, K.; Nagahama, H.; Minamishima, Y. A.; Matsumoto, M.; Nakamichi, I.; Kitagawa, K.; Shirane, M.; Tsunematsu, R.; Tsukiyama, T.; Ishida, N.; Kitagawa, M.; Hatakeyama, S. Targeted Disruption of Skp2 Results in Accumulation of Cyclin E and P27(Kip1), Polyploidy and Centrosome Overduplication. EMBO J. 2000, 19, 2069-2081.
60. Palazzo, R. E.; Vogel, J. M.; Schnackenberg, B. J.; Hull, D. R.; Wu, X. Centrosome Maturation. Curr. Top. Dev. Biol. 2000, 49, 449-470.
61. do Carmo Avides, M.; Tavares, A.; Glover, D. M. Polo Kinase and Asp Are Needed to Promote the Mitotic Organizing Activity of Centrosomes. Nat. Cell Biol. 2001, 3, 421-424.
62. Fry, A. M.; Meraldi, P.; Nigg, E. A. A Centrosomal Function for the Human Nek2 Protein Kinase, a Member of the Nima Family of Cell Cycle Regulators. EMBO J. 1998, 17, 470-481.
63. Uto, K.; Sagata, N. Nek2b, a Novel Maternal Form of Nek2 Kinase, Is Essential for the Assembly or Maintenance of Centrosomes in Early Xenopus Embryos. EMBO J. 2000, 19, 1816-1826.
64. Carazo-Salas, R. E.; Gruss, O. J.; Mattaj, I. W.; Karsenti, E. Ran-Gtp Coordinates Regulation of Microtubule Nucleation and Dynamics During Mitotic-Spindle Assembly. Nat. Cell Biol. 2001, 3, 228-234.
65. Goepfert, T. M.; Brinkley, B. R. The Centrosome-Associated Aurora/Ip1-Like Kinase Family. Curr. Top. Dev. Biol. 2000, 49, 331-342.
66. Mayor, T.; Stierhof, Y. D.; Tanaka, K.; Fry, A. M.; Nigg, E. A. The Centrosomal Protein C-Nap1 Is Required for Cell Cycle-Regulated Centrosome Cohesion. J. Cell Biol. 2000, 151, 837-846.
67. Rieder, C. L.; Faruki, S.; Khodjakov, A. The Centrosome in Vertebrates: More Than a Microtubule-Organizing Center. Trends Cell Biol. 2001, 11, 413-419.
68. Fukasawa, K.; Choi, T.; Kuriyama, R.; Rulong, S.; Vande Woude, G. F. Abnormal Centrosome Amplification in the Absence of p53. Science 1996, 271, 1744-1747.
69. Carroll, P. E.; Okuda, M.; Horn, H. F.; Biddinger, P.; Stambrook, P. J.; Gleich, L. L.; Li, Y. Q.; Tarapore, P.; Fukasawa, K. Centrosome Hyperamplification in Human Cancer: Chromosome Instability Induced by p53 Mutation and/or Mdm2 Overexpression. Oncogene 1999, 18, 1935-1944.
70. Mantel, C.; Braun, S. E.; Reid, S.; Henegariu, O.; Liu, L.; Hangoc, G.; Broxmeyer, H. E. P21(Cip-1/Waf-1) Deficiency Causes Deformed Nuclear Architecture, Centriole Overduplication, Polyploidy, and Relaxed Microtubule Damage Checkpoints in Human Hematopoietic Cells. Blood 1999, 93, 1390-1398.
71. Hollander, M. C.; Sheikh, M. S.; Bulavin, D. V.; Lundgren, K.; Augeri-Henmueller, L.; Shehee, R.; Molinaro, T. A.; Kim, K. E.; Tolosa, E.; Ashwell, J. D.; Rosenberg, M. P.; Zhan, Q.; Fernandez-Salguero, P. M.; Morgan, W. F.; Deng, C. X.; Fornace, A. J., Jr. Genomic Instability in Gadd45a-Deficient Mice. Nat. Genet. 1999, 23, 176-184.
72. Xu, X.; Weaver, Z.; Linke, S. P.; Li, C.; Gotay, J.; Wang, X. W.; Harris, C. C.; Ried, T.; Deng, C. X. Centrosome Amplification and a Defective G2-M Cell Cycle Checkpoint Induce Genetic Instability in Brca1 Exon 11 Isoform-Deficient Cells. Mol. Cell. 1999, 3, 389-395.
73. Tutt, A.; Gabriel, A.; Bertwistle, D.; Connor, F.; Paterson, H.; Peacock, J.; Ross, G.; Ashworth, A. Absence of Brca2 Causes Genome Instability by Chromosome Breakage and Loss Associated with Centrosome Amplification. Curr. Biol. 1999, 9, 1107-1110.
74. Smith, L.; Liu, S. J.; Goodrich, L.; Jacobson, D.; Degnin, C.; Bentley, N.; Carr, A.; Flaggs, G.; Keegan, K.; Hoekstra, M.; Thayer, M. J. Duplication of Atr Inhibits Myod, Induces Aneuploidy and Eliminates Radiation-Induced G1 Arrest. Nat. Genet. 1998, 19, 39-46.
75. Xie, W.; Li, L.; Cohen, S. N. Cell Cycle-Dependent Subcellular Localization of the Tsg101 Protein and Mitotic and Nuclear Abnormalities Associated with Tsg101 Deficiency. Proc. Natl. Acad. Sci. USA 1998, 95, 1595-1600.
76. Zhou, H.; Kuang, J.; Zhong, L.; Kuo, W. L.; Gray, J. W.; Sahin, A.; Brinkley, B. R.; Sen, S. Tumour Amplified Kinase Stk15/Btak Induces Centrosome Amplification, Aneuploidy and Transformation. Nat. Genet. 1998, 20, 189-193.
77. Meraldi, P.; Honda, R.; Nigg, E. A. Aurora-a Overexpression Reveals Tetraploidization as a Major Route to Centrosome Amplification in P53-/- Cells. EMBO J. 2002, 21, 483-492.
78. Brinkley, B. R. Managing the Centrosome Numbers Game: From Chaos to Stability in Cancer Cell Division. Trends Cell Biol. 2001, 11, 18-21.
79. Duensing, S.; Munger, K. Centrosome Abnormalities, Genomic Instability and Carcinogenic Progression. Biochim. Biophys. Acta 2001, 1471, M81-M8.
80. Kramer, A.; Neben, K.; Ho, A. D. Centrosome Replication, Genomic Instability and Cancer. Leukemia 2002, 16, 767-75.
81. Lingle, W. L.; Salisbury, J. L. The Role of the Centrosome in the Development of Malignant Tumors. Curr. Top. Dev. Biol. 2000, 49, 313-329.
82. Pihan, G. A.; Doxsey, S. J. The Mitotic Machinery as a Source of Genetic Instability in Cancer. Semin. Cancer Biol. 1999, 9, 289-302.
83. Pihan, G. A.; Purohit, A.; Wallace, J.; Malhotra, R.; Liotta, L.; Doxsey, S. J. Centrosome Defects Can Account for Cellular and Genetic Changes That Characterize Prostate Cancer Progression. Cancer Res. 2001, 61, 2212-2219.
84. Shono, M.; Sato, N.; Mizumoto, K.; Maehara, N.; Nakamura, M.; Nagai, E.; Tanaka, M. Stepwise Progression of Centrosome Defects Associated with Local Tumor Growth and Metastatic Process of Human Pancreatic Carcinoma Cells Transplanted Orthotopically into Nude Mice. Lab. Invest. 2001, 81, 945-952.
85. Hinchcliffe, E. H.; Miller, F. J.; Cham, M.; Khodjakov, A.; Sluder, G. Requirement of a Centrosomal Activity for Cell Cycle Progression through G1 into S Phase. Science 2001, 291, 1547-1550.
86. Khodjakov, A.; Rieder, C. L. Centrosomes Enhance the Fidelity of Cytokinesis in Vertebrates and Are Required for Cell Cycle Progression. J. Cell Biol. 2001, 153, 237-242.
87. Piel, M.; Nordberg, J.; Euteneuer, U.; Bornens, M. Centrosome-Dependent Exit of Cytokinesis in Animal Cells. Science 2001, 291, 1550-3.
88. Loeb, L. A. A Mutator Phenotype in Cancer. Cancer Res. 2001, 61, 3230-3239.
89. Blagosklonny, M. V.; Fojo, T. Molecular Effects of Paclitaxel: Myths and Reality (a Critical Review). Int. J. Cancer 1999, 83, 151-156.
90. Gazitt, Y.; Rothenberg, M. L.; Hilsenbeck, S. G.; Fey, V.; Thomas, C.; Montegomrey, W. Bcl-2 Overexpression Is Associated with Resistance to Paclitaxel, but Not Gemcitabine, in Multiple Myeloma Cells. Int. J. Oncol. 1998, 13, 839-848.
91. Tang, C.; Willingham, M. C.; Reed, J. C.; Miyashita, T.; Ray, S.; Ponnathpur, V.; Huang, Y.; Mahoney, M. E.; Bullock, G.; Bhalla, K. High Levels of P26bcl-2 Oncoprotein Retard Taxol-Induced Apoptosis in Human Pre-B Leukemia Cells. Leukemia 1994, 8, 1960-1969.
92. Liu, J. R.; Fletcher, B.; Page, C.; Hu, C.; Nunez, G.; Baker, V. Bcl-XI Is Expressed in Ovarian Carcinoma and Modulates Chemotherapy-Induced Apoptosis. Gynecol. Oncol. 1998, 70, 398-403.
93. Sumantran, V. N.; Ealovega, M. W.; Nunez, G.; Clarke, M. F.; Wicha, M. S. Overexpression of Bcl-Xs Sensitizes Mcf-7 Cells to Chemotherapy-Induced Apoptosis. Cancer Res. 1995, 55, 2507-2510.
94. Jones, N. A.; Turner, J.; McIlwrath, A. J.; Brown, R.; Dive, C. Cisplatin- and Paclitaxel-Induced Apoptosis of Ovarian Carcinoma Cells and the Relationship between Bax and Bak up-Regulation and the Functional Status of P53. Mol. Pharmacol. 1998, 53, 819-826.
95. Strobel, T.; Tai, Y. T.; Korsmeyer, S.; Cannistra, S. A. Bad Partly Reverses Paclitaxel Resistance in Human Ovarian Cancer Cells. Oncogene 1998, 17, 2419-2427.
96. Strobel, T.; Swanson, L.; Korsmeyer, S.; Cannistra, S. A. Bax Enhances Paclitaxel-Induced Apoptosis through a P53-Independent Pathway. Proc. Natl. Acad. Sci. USA 1996, 93, 14094-14099.
97. Basu, A.; Haldar, S. Microtubule-Damaging Drugs Triggered Bcl2 Phosphorylation-Requirement of Phosphorylation on Both Serine-70 and Serine-87 Residues of Bcl2 Protein. Int. J. Oncol. 1998, 13, 659-664.
98. Blagosklonny, M. V. Unwinding the Loop of Bcl-2 Phosphorylation. Leukemia 2001, 15, 869-874.
99. Haldar, S.; Basu, A.; Croce, C. M. Bcl2 Is the Guardian of Microtubule Integrity. Cancer Res. 1997, 57, 229-233.
100. Scatena, C. D.; Stewart, Z. A.; Mays, D.; Tang, L. J.; Keefer, C. J.; Leach, S. D.; Pietenpol, J. A. Mitotic Phosphorylation of Bcl-2 During Normal Cell Cycle Progression and Taxol-Induced Growth Arrest. J. Biol. Chem. 1998, 273, 30777-30784.
101. Ling, Y. H.; Tornos, C.; Perez-Soler, R. Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis. J. Biol. Chem. 1998, 273, 18984-18991.
102. Donaldson, K. L.; Goolsby, G. L.; Kiener, P. A.; Wahl, A. F. Activation of P34cdc2 Coincident with Taxol-Induced Apoptosis. Cell Growth Differ. 1994, 5, 1041-1050.
103. Ling, Y. H.; Consoli, U.; Tornos, C.; Andreeff, M.; Perez-Soler, R. Accumulation of Cyclin B1, Activation of Cyclin B1-Dependent Kinase and Induction of Programmed Cell Death in Human Epidermoid Carcinoma Kb Cells Treated with Taxol. Int. J. Cancer 1998, 75, 925-932.
104. Blagosklonny, M. V.; Giannakakou, P.; el-Deiry, W. S.; Kingston, D. G.; Higgs, P. I.; Neckers, L.; Fojo, T. Raf-1/Bcl-2 Phosphorylation: A Step from Microtubule Damage to Cell Death. Cancer Res. 1997, 57, 130-135.
105. Blagosklonny, M. V.; Schulte, T.; Nguyen, P.; Trepel, J.; Neckers, L. M. Taxol-Induced Apoptosis and Phosphorylation of Bcl-2 Protein Involves C-Raf-1 and Represents a Novel C-Raf-1 Signal Transduction Pathway. Cancer Res. 1996, 56, 1851-1854.
106. Mabuchi, S.; Ohmichi, M.; Kimura, A.; Hisamoto, K.; Hayakawa, J.; Nishio, Y.; Adachi, K.; Takahashi, K.; Arimoto-Ishida, E.; Nakatsuzi, Y.; Tasaka, K.; Murata, Y. Inhibition of Phosphorylation of Bad and Raf-1 by Akt Sensitizes Human Ovarian Cancer Cells to Paclitaxel. J. Biol. Chem. 2002, 26, 26
107. Ibrado, A. M.; Liu, L.; Bhalla, K. Bcl-X1 Overexpression Inhibits Progression of Molecular Events Leading to Paclitaxel-Induced Apoptosis of Human Acute Myeloid Leukemia H1-60 Cells. Cancer Res. 1997, 57, 1109-1115.
108. Britten, R. A.; Perdue, S.; Eshpeter, A.; Merriam, D. Raf-1 Kinase Activity Predicts for Paclitaxel Resistance in Tp53mut, but Not Tp53wt Human Ovarian Cancer Cells. Oncol. Rep. 2000, 7, 821-825.
109. Bacus, S. S.; Gudkov, A. V.; Lowe, M.; Lyass, L.; Yung, Y.; Komarov, A. P.; Keyomarsi, K.; Yarden, Y.; Seger, R. Taxol-Induced Apoptosis Depends on Map Kinase Pathways (Erk and P38) and Is Independent of p53. Oncogene 2001, 20, 147-155.
110. Blagosklonny, M. V.; Chuman, Y.; Bergan, R. C.; Fojo, T. Mitogen-Activated Protein Kinase Pathway Is Dispensable for Microtubule-Active Drug-Induced Raf-1/Bcl-2 Phosphorylation and Apoptosis in Leukemia Cells. Leukemia 1999, 13, 1028-1036.
111. McDaid, H. M.; Horwitz, S. B. Selective Potentiation of Paclitaxel (Taxol)-Induced Cell Death by Mitogen-Activated Protein Kinase Kinase Inhibition in Human Cancer Cell Lines. Mol. Pharmacol. 2001, 60, 290-301.
112. Stone, A. A.; Chambers, T. C. Microtubule Inhibitors Elicit Differential Effects on Map Kinase (Jnk, Erk, and p38) Signaling Pathways in Human Kb-3 Carcinoma Cells. Exp. Cell Res. 2000, 254, 110-119.
113. Lee, L. F.; Li, G.; Templeton, D. J.; Ting, J. P. Paclitaxel (Taxol)-Induced Gene Expression and Cell Death Are Both Mediated by the Activation of C-Jun Nh2-Terminal Kinase (Jnk/Sapk). J. Biol. Chem. 1998, 273, 28253-28260.
114. Wang, T. H.; Wang, H. S.; Ichijo, H.; Giannakakou, P.; Foster, J. S.; Fojo, T.; Wimalasena, J. Microtubule-Interfering Agents Activate C-Jun N-Terminal Kinase/Stress-Activated Protein Kinase through Both Ras and Apoptosis Signal-Regulating Kinase Pathways. J. Biol. Chem. 1998, 273, 4928-4936.
115. Yamamoto, K.; Ichijo, H.; Korsmeyer, S. J. Bcl-2 Is Phosphorylated and Inactivated by an Ask1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G(2)/M. Mol. Cell Biol. 1999, 19, 8469-8478.
116. Wang, T. H.; Popp, D. M.; Wang, H. S.; Saitoh, M.; Mural, J. G.; Henley, D. C.; Ichijo, H.; Wimalasena, J. Microtubule Dysfunction Induced by Paclitaxel Initiates Apoptosis through Both C-Jun N-Terminal Kinase (Jnk)-Dependent and -Independent Pathways in Ovarian Cancer Cells. J. Biol. Chem. 1999, 274, 8208-8216.
117. Biswas, R. S.; Cha, H. J.; Hardwick, J. M.; Srivastava, R. K. Inhibition of Drug-Induced Fas Ligand Transcription and Apoptosis by Bcl-XI. Mol. Cell. Biochem. 2001, 225, 7-20.
118. Blagosklonny, M. V.; Robey, R.; Sheikh, M. S.; Fojo, T. Paclitaxel-Induced FasL-Independent Apoptosis and Slow (Non-Apoptotic) Cell Death. Cancer Biol. Ther. 2002, 1, 113-117.
119. Cross, S. M.; Sanchez, C. A.; Morgan, C. A.; Schimke, M. K.; Ramel, S.; Idzerda, R. L.; Raskind, W. H.; Reid, B. J. A P53-Dependent Mouse Spindle Checkpoint. Science 1995, 267, 1353-1356.
120. Khan, S. H.; Wahl, G. M. P53 and Prb Prevent Rereplication in Response to Microtubule Inhibitors by Mediating a Reversible G1 Arrest. Cancer Res. 1998, 58, 396-401.
121. Lanni, J. S.; Jacks, T. Characterization of the P53-Dependent Postmitotic Checkpoint Following Spindle Disruption. Mol. Cell Biol. 1998, 18, 1055-1064.
122. Wahl, A. F.; Donaldson, K. L.; Fairchild, C.; Lee, F. Y.; Foster, S. A.; Demers, G. W.; Galloway, D. A. Loss of Normal P53 Function Confers Sensitization to Taxol by Increasing G2/M Arrest and Apoptosis. Nat. Med. 1996, 2, 72-79.
123. Giannakakou, P.; Robey, R.; Fojo, T.; Blagosklonny, M. V. Low Concentrations of Paclitaxel Induce Cell Type-Dependent P53, P21 and G1/G2 Arrest Instead of Mitotic Arrest: Molecular Determinants of Paclitaxel-Induced Cytotoxicity. Oncogene 2001, 20, 3806-3813.
124. Trielli, M. O.; Andreassen, P. R.; Lacroix, F. B.; Margolis, R. L. Differential Taxol-Dependent Arrest of Transformed and Nontransformed Cells in the G1 Phase of the Cell Cycle, and Specific-Related Mortality of Transformed Cells. J. Cell Biol. 1996, 135, 689-700.
125. Stewart, Z. A.; Mays, D.; Pietenpol, J. A. Defective G1-S Cell Cycle Checkpoint Function Sensitizes Cells to Microtubule Inhibitor-Induced Apoptosis. Cancer Res. 1999, 59, 3831-3837.
126. Fan, S.; Cherney, B.; Reinhold, W.; Rucker, K.; O'Connor, P. M. Disruption of p53 Function in Immortalized Human Cells Does Not Affect Survival or Apoptosis after Taxol or Vincristine Treatment. Clin. Cancer Res. 1998, 4, 1047-1054.
127. Lanni, J. S.; Lowe, S. W.; Licitra, E. J.; Liu, J. O.; Jacks, T. P53-Independent Apoptosis Induced by Paclitaxel through an Indirect Mechanism. Proc. Natl. Acad. Sci. USA 1997, 94, 9679-9683.
128. Blajeski, A. L.; Kottke, T. J.; Kaufmann, S. H. A Multistep Model for Paclitaxel-Induced Apoptosis in Human Breast Cancer Cell Lines. Exp. Cell Res. 2001, 270, 277-288.
129. Hawkins, D. S.; Demers, G. W.; Galloway, D. A. Inactivation of p53 Enhances Sensitivity to Multiple Chemotherapeutic Agents. Cancer Res. 1996, 56, 892-898.
130. Perego, P.; Romanelli, S.; Carenini, N.; Magnani, I.; Leone, R.; Bonetti, A.; Paolicchi, A.; Zunino, F. Ovarian Cancer Cisplatin-Resistant Cell Lines: Multiple Changes Including Collateral Sensitivity to Taxol. Ann. Oncol. 1998, 9, 423-340.
131. Zhang, C. C.; Yang, J. M.; White, E.; Murphy, M.; Levine, A.; Hait, W. N. The Role of Map4 Expression in the Sensitivity to Paclitaxel and Resistance to Vinca Alkaloids in p53 Mutant Cells. Oncogene 1998, 16, 1617-1624.
132. Debernardis, D.; Sire, E. G.; De Feudis, P.; Vikhanskaya, F.; Valenti, M.; Russo, P.; Parodi, S.; D'Incalci, M.; Broggini, M. p53 Status Does Not Affect Sensitivity of Human Ovarian Cancer Cell Lines to Paclitaxel. Cancer Res. 1997, 57, 870-874.
133. O'Connor, P. M.; Jackman, J.; Bae, I.; Myers, T. G.; Fan, S.; Mutoh, M.; Scudiero, D. A.; Monks, A.; Sausville, E. A.; Weinstein, J. N.; Friend, S.; Fornace, A. J., Jr.; Kohn, K. W. Characterization of the p53 Tumor Suppressor Pathway in Cell Lines of the National Cancer Institute Anticancer Drug Screen and Correlations with the Growth-Inhibitory Potency of 123 Anticancer Agents. Cancer Res. 1997, 57, 4285-4300.
134. Giannakakou, P.; Nakano, M.; Nicolaou, K. C.; O'Brate, A.; Yu, J.; Blagosklonny, M. V.; Greber, U. F.; Fojo, T. Enhanced Microtubule-Dependent Trafficking and p53 Nuclear Accumulation by Suppression of Microtubule Dynamics. Proc. Natl. Acad. Sci. USA 2002, 99, 10855-10860.
135. Miyashita, T.; Reed, J. C. Tumor Suppressor P53 Is a Direct Transcriptional Activator of the Human Bax Gene. Cell 1995, 80, 293-299.
136. Kartner, N.; Riordan, J. R.; Ling, V. Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines. Science 1983, 221, 1285-1288.
137. Cabral, F. Factors Determining Cellular Mechanisms of Resistance to Antimitotic Drugs. Drug Resist. Updat. 2001, 4, 3-8.
138. Goncalves, A.; Braguer, D.; Kamath, K.; Martello, L.; Briand, C.; Horwitz, S.; Wilson, L.; Jordan, M. A. Resistance to Taxol in Lung Cancer Cells Associated with Increased Microtubule Dynamics. Proc. Natl. Acad. Sci. USA 2001, 98, 11737-11742.
139. Dumontet, C.; Sikic, B. I. Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death. J. Clin. Oncol. 1999, 17, 1061-1070.
140. Burkhart, C. A.; Kavallaris, M.; Band Horwitz, S. The Role of Beta-Tubulin Isotypes in Resistance to Antimitotic Drugs. Biochim. Biophys. Acta 2001, 1471, 1-9.
141. Giannakakou, P.; Sackett, D. L.; Kang, Y. K.; Zhan, Z.; Buters, J. T.; Fojo, T.; Poruchynsky, M. S. Paclitaxel-Resistant Human Ovarian Cancer Cells Have Mutant Beta-Tubulins That Exhibit Impaired Paclitaxel-Driven Polymerization. J. Biol. Chem. 1997, 272, 17118-17125.
142. Shah, M. A.; Schwartz, G. K. Cell Cycle-Mediated Drug Resistance: An Emerging Concept in Cancer Therapy. Clin. Cancer Res. 2001, 7, 2168-2181.
143. Carlson, B. A.; Dubay, M. M.; Sausville, E. A.; Brizuela, L.; Worland, P. J. Flavopiridol Induces G1 Arrest with Inhibition of Cyclin-Dependent Kinase (Cdk) 2 and Cdk4 in Human Breast Carcinoma Cells. Cancer Res. 1996, 56, 2973-2978.
144. Motwani, M.; Delohery, T. M.; Schwartz, G. K. Sequential Dependent Enhancement of Caspase Activation and Apoptosis by Flavopiridol on Paclitaxel-Treated Human Gastric and Breast Cancer Cells. Clin. Cancer Res. 1999, 5, 1876-1883.
145. Bible, K. C.; Kaufmann, S. H. Cytotoxic Synergy between Flavopiridol (Nsc 649890, L86-8275) and Various Antineoplastic Agents: The Importance of Sequence of Administration. Cancer Res. 1997, 57, 3375-3380.
146. Zaffaroni, N.; Silvestrini, R.; Orlandi, L.; Bearzatto, A.; Gornati, D.; Villa, R. Induction of Apoptosis by Taxol and Cisplatin and Effect on Cell Cycle-Related Proteins in Cisplatin-Sensitive and -Resistant Human Ovarian Cells. Br. J. Cancer 1998, 77, 1378-1385.
147. Judson, P. L.; Watson, J. M.; Gehrig, P. A.; Fowler, W. C., Jr.; Haskill, J. S. Cisplatin Inhibits Paclitaxel-Induced Apoptosis in Cisplatin-Resistant Ovarian Cancer Cell Lines: Possible Explanation for Failure of Combination Therapy. Cancer Res. 1999, 59, 2425-2432.
148. Milross, C. G.; Peters, L. J.; Hunter, N. R.; Mason, K. A.; Milas, L. Sequence-Dependent Antitumor Activity of Paclitaxel (Taxol) and Cisplatin in Vivo. Int. J. Cancer 1995, 62, 599-604.
149. Rowinsky, E. K.; Citardi, M. J.; Noe, D. A.; Donehower, R. C. Sequence-Dependent Cytotoxic Effects Due to Combinations of Cisplatin and the Antimicrotubule Agents Taxol and Vincristine. J Cancer Res. Clin. Oncol. 1993, 119, 727-733.
150. Blagosklonny, M. V.; Robey, R.; Bates, S.; Fojo, T. Pretreatment with DNA-Damaging Agents Permits Selective Killing of Checkpoint-Deficient Cells by Microtubule-Active Drugs. J. Clin. Invest. 2000, 105, 533-539.
151. Blagosklonny, M. V.; Darzynkiewicz, Z.; Figg, W. D. Flavopiridol Inversely Affects p21(Waf1/Cip1) and p53 and Protects p21-Sensitive Cells from Paclitaxel. Cancer Biol. Ther. 2002, 1, 420-425.
152. Wang, L. G.; Liu, X. M.; Kreis, W.; Budman, D. R. The Effect of Antimicrotubule Agents on Signal Transduction Pathways of Apoptosis: A Review. Cancer Chemother. Pharmacol. 1999, 44, 355-361.